When the Golden State Warriors’ head of sports medicine, Chelsea Lane, first approached assistant general manager Kirk Lacob in the front office with a new device last summer, she explained that Eye-Sync would help the team quickly and objectively assess whether a player might be suffering from concussion symptoms. The Warriors had endured a few instances in recent playoffs when they weren’t sure of a player’s readiness and were always looking to improve upon the NBA’s defined protocol for evaluation.
Lane later returned with an Eye-Sync device sent along for trial purposes by SyncThink, the brainchild of Stanford neurosurgeon Dr.